Kronowitz Steven J, Robb Geoffrey L
Houston, Texas From the Department of Plastic Surgery, University of Texas M. D. Anderson Cancer Center.
Plast Reconstr Surg. 2009 Aug;124(2):395-408. doi: 10.1097/PRS.0b013e3181aee987.
The optimal timing and technique of breast reconstruction in patients who may require postmastectomy radiation therapy are controversial. To help surgeons make the best decisions, the authors reviewed the recent literature on this topic.
The authors searched the MEDLINE database for studies of radiation therapy and breast reconstruction with most patients treated after 1985 and mean follow-up of more than 1 year. Forty-nine articles were reviewed.
Even with the latest prosthetic materials and modern radiation delivery techniques, the complication rate for implant-based breast reconstruction in patients undergoing postmastectomy radiation therapy is greater than 40 percent, and the extrusion rate is 15 percent. Modified sequencing of two-stage implant reconstruction, such that the expander is exchanged for the permanent implant before postmastectomy radiation therapy, results in higher rates of capsular contracture and is not generally feasible after neoadjuvant chemotherapy. Current evidence suggests that postmastectomy radiation therapy also adversely affects autologous tissue reconstruction. Even with modern radiation delivery techniques, immediate implant-based or autologous tissue breast reconstruction can distort the chest wall and limit the ability to treat the targeted tissues without excessive exposure of the heart and lungs. In patients for whom postmastectomy radiation therapy appears likely but may not be required, "delayed-immediate reconstruction," in which tissue expanders are placed at mastectomy, avoids the difficulties associated with radiation delivery after immediate reconstruction and preserves the opportunity for the aesthetic benefits of skin-sparing mastectomy.
In patients who will receive or have already received postmastectomy radiation therapy, the optimal approach is delayed autologous tissue reconstruction after postmastectomy radiation therapy. If postmastectomy radiation therapy appears likely but may not be required, delayed-immediate reconstruction may be considered.
对于可能需要术后放疗的患者,乳房重建的最佳时机和技术存在争议。为帮助外科医生做出最佳决策,作者回顾了关于该主题的近期文献。
作者在MEDLINE数据库中搜索了1985年后治疗的大多数患者且平均随访超过1年的放疗与乳房重建研究。共回顾了49篇文章。
即使采用最新的假体材料和现代放疗技术,接受术后放疗的患者采用植入物乳房重建的并发症发生率仍超过40%,挤出率为15%。两阶段植入物重建的改良顺序,即扩张器在术后放疗前更换为永久性植入物,会导致包膜挛缩率更高,且在新辅助化疗后通常不可行。目前的证据表明,术后放疗也会对自体组织重建产生不利影响。即使采用现代放疗技术,即刻植入物或自体组织乳房重建也可能使胸壁变形,并限制在不过度暴露心脏和肺部的情况下治疗目标组织的能力。对于那些术后放疗似乎有可能但不一定需要的患者,“延迟即刻重建”(即在乳房切除时放置组织扩张器)可避免即刻重建后放疗带来的困难,并保留了保留皮肤乳房切除术美学效果的机会。
对于将接受或已接受术后放疗的患者,最佳方法是术后放疗后延迟自体组织重建。如果术后放疗似乎有可能但不一定需要,可考虑延迟即刻重建。